Search

Search Constraints

You searched for: Author/Creator Zhang, W.

Search Results

1. 134P Safety and efficacy of multi-target TKI combined with nivolumab in checkpoint inhibitor-refractory advanced NSCLC patients: A prospective, single arm, two stage study. (December 2022)

2. 135P Camrelizumab plus chemotherapy as first-line therapy for NSCLC: A pooled analysis of two randomized phase III trials with extended follow-up. (December 2022)

4. 2008 Non-Invasive testing of gene expressions using cell-free RNA increases the chemotherapy target information generated from cell-free DNA testing. (September 2015)

5. 2010 A genetic variant in RASSF1A, a key regulator of HIPPO pathway, predicts survival in two independent cohorts of mCRC patients treated with cetuximab-based chemotherapy. (September 2015)

7. 2572 Clinical and translational assessment of VEGFR1 as a mediator of the pre-metastatic niche: Neoadjuvant axitinib in high-risk localized prostate cancer. (September 2015)